Beacon Therapeutics may have found a guiding light in a disease area where other companies have stumbled with its ...

Jiarui Nie, a postdoctoral researcher at the National Institutes of Health, is exploring how gold nanoparticles injected into ...

Scientists have achieved long-term retina regeneration in mammals. The research has the potential to reverse blindness in ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Johnson & Johnson bought the full rights to a rare disease gene therapy a few years ago, but now the Big Pharma may be ...

The grant will support the company’s ongoing clinical development of RTx-015 for the treatment of retinitis pigmentosa (RP), a progressive and debilitating inherited retinal disease that leads ...

Blueberries are a superfood that can provide substantial health benefits. They’re packed with nutrients, such as fiber, vitamin C, and manganese. Blueberries also contain special antioxidants that may ...

Retinal regeneration and visual recovery in a retinitis pigmentosa model mouse through Anti-PROX1 gene therapy. After administration of adeno-associated virus expressing PROX1 neutralizing antibodies ...

Significant advances have been made in the understanding of the genetics of retinitis pigmentosa (RP), a clinically and genetically heterogeneous group of disorders; and over 50 genes underlying ...

The presentation is titled, "Subretinal gene therapy laru-zova (AGTC-501) for X-linked retinitis pigmentosa (XLRP): Phase 2 DAWN preliminary month 6 results" and will be given by Mark Pennesi, MD, PhD ...

Retinal disorders like macular degeneration and retinitis pigmentosa affect millions of people in the U.S. and around the world. These conditions damage light-sensitive cells in the retina called ...

BLOOM (TAMPA) – Retinitis Pigmentosa (RP) is a rare genetic eye disorder that causes the retina’s cells to break down over time, leading to progressive vision loss—often starting with ...